About usSign in
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Biotechnology
About
ALS Investment Fund invests in biotech companies focusing on neurodegenerative diseases like ALS, Alzheimer's disease, and Parkinson’s disease. They emphasize companies with strong founders and cuttingedge technologies, with a preference for those having platform approaches relevant to multiple diseases or multiple drugs in clinical development. Their portfolio includes companies that have proven the basic science behind their approaches and are working towards a value inflection point. Notable investments include Amylyx, Orphazyme, Emulate, Verge Genomics, Apic Bio, Prilenia, QurAlis, and Bloom Science.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

They invest in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus in ALS.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Felix von Coerper

Melanie Leitner

Craig Boyce

Rist Brouwer

Dr. Robert Brown

Dr. Kuldip Dave

Dr. Merit Cudkowicz

Prof. Leonard van den Berg

Dr. Fernando Vieira

Dr. Alan Walts

Portfolio

Amylyx

Orphazyme

Emulate

Verge Genomics

Apic Bio

Prilenia

QurAlis

Bloom Science

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp